Having trouble reading this newsletter? Click here to see it in your browser.
You are receiving this newsletter because you signed up from our web site. Click here to unsubscribe.
forward to a friend
12 January 2010
Current Partnering Newsletter

Dealmakers Update - January 2010

Sponsored this month by:

BioNetwork East

At BioNetwork East taking place March 15-17 in Miami Beach, FL you’ll meet global biotech and pharmaceutical companies ready to partner.

Register online at www.BioNetworkEast.com or call 646-200-7530.

Mention your code 10840.004XZ884NL to get 25% off.


  • Editor's corner
  • In the news
  • Scorecard update
  • Partnering roundup
  • Best practice articles
  • Forthcoming events
  • Latest business reports
  • On the move - latest updates

Editor's corner

Happy new year to all our dealmaker readers!

Hopefully, 2010 will be a year of growth for biopharma, with commercialization of promising new drugs via partnering and M&A. For all the challenges of the past twelve months, we must never lose focus on the main challenge - improving peoples lives through health. The new year will provide many challenges but also huge opportunities.

Now is the time to start planning your partnering event attendance for 2010 - the following are our suggested must attend events: Biobusiness 2010, Biopartnering North America, Drug Delivery Partnerships, BioEurope Spring, plus the new combined BioWindhover/Pharmaceutical Strategic Outlook 2010. In addition, the new and innovative PharmaPartneringLive 2010 seeks to provide the first completely virtual partnering event in May 2010.

NEW FOR 2010 Due to popular demand, we have added a new interim newsletter - Dealmakers Round-Up. This new newsletter is delivered to  all our recipients towards the end of each month, providing up to the minute access to our industry round-up and in the news sections cthat ontinue to provide insight and are updated daily online, providing you with the latest trends from the world's most respected publishers and deal news direct from biopharma companies as they are announced.

You can also follow these updates via our LinkedIn and Twitter pages - sign up here.

Our latest report: Drug Delivery Partnering Agreements in Pharma and Biotech is now available, providing insight and access to hundreds of partnering contract documents.

Our publishing arm has been busy introducing new reports - here are just a few of the titles to facilitate partnering in 2010:

All for now!

-- Steve Poile --


In the news

The following are just some of the deals involving bigpharma announced in the last few weeks:

Deals of note so far in January 2010:

  •  Sanofi-Aventis commences tender offer for Chattem
  •  AnaptysBio in agreement with Roche to develop novel antibodies
  • KaloBios partners with Sanofi Pasteur on novel prevention and treatment for Pseudomonas aeruginosa
  • GlaxoSmithKline in Traficet-EN licensing deal with ChemoCentryx
  • BioMimetic strengthens agreement with Novartis Vaccines & Diagnostics for exclusive supply of rhPDGF-BB
  • Clinical candidate from PKB/AKT collaboration with Astex Therapeutics selected by AstraZeneca
  • AstraZeneca in deal with Teva for Nexium
  • Pfizer and Debiopharm collaborate to co-develop Tremelimumab in advanced melanoma

Keep posted on the latest deals and alliances with CurrentPartnering's In the news feature.

Signup for our updates via LinkedIn and Twitter.


Partnering roundup

Just some of the articles picked up by Roundup during early January:

  • Big Firms Will Fight The Patent Cliff
  •  Icahn Considering Proxy Battle at Genzyme
  • Teva’s Yanai Forecasts $31 Billion in Revenue by 2015
  • Merck And Pfizer Plan 900 Job Cuts
  • FDA Drug Approvals in 2009 - Up (a Little) from 2008
  • Top 10 outsourcing trends for 2010
  • Biogen Idec Launches Search for New CEO
  • Lilly Taps Contractors to Revive Pipeline

Follow Roundup online here

Signup for our updates via LinkedIn and Twitter.


Scorecard update

Updated today - January 12, 2010

Our Scorecard Index provides a simple overview of recent partnering and M&A activity - see it now - Scorecard Index.

Updated monthly - we will be updating our Scorecard Index - tracking partnering and M&A deals announced every month.

In additon, we track the leading deals by value in the current year, plus a compendium of top deals by value since 2000 - view details at Scorecard.

Latest update! Bigpharma partnering activity 2006 to present - view details here


Best practice articles

Barcelona plays host to BIO-Europe Spring 2010

The 4th edition of BIO-Europe Spring® will attract leaders from the international biotech industry to Barcelona, Spain on March 8-10, where local host BioRegion of Catalonia (Biocat) promises to surprise attendees with opportunities for projects, products and investments more

Royalty Rates For Technology Transactions

An interesting study was carried out between 1990 and 2007 which discovered that the most frequently negotiated royalty rate is 5% of net sales more

Big Pharma seeks to insulate itself from impact of ‘patent cliff’

As the pharmaceutical industry hurtles ever closer towards the ‘patent cliff’, Big Pharma* is busy implementing strategies to lessen the impact of the loss of patent protection on some of the industry’s biggest sellers on their collective bottom lines more

Tell Them Clearly What You’re Not Interested In!

One of the challenges prior to each partnering conference is the issue of other delegates asking you for a meeting to discuss an opportunity which you are not interested in more

Read all our partnering best practice articles.


New and updated reports

New report titles:

CurrentPartnering has published new titles:

Drug Delivery Partnering Agreements in Pharma, Biotech and Diagnostics

Provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds leading companies

  • Comprehensive directory of drug delivery deals since 2003
  • Drug delivery contract documents
  • Drug delivery agreement terms
  • Drug delivery agreement structure
  • Top drug delivery deals by value
  • Most active drug delivery dealmakers
  • Access links to over 800 actual drug delivery contract agreements

More details and order

Partnering Agreements in Diagnostics

Providing detailed understanding and analysis of how and why companies enter diagnostic partnering deals, plus access to actual diagnostic agreements

  • Comprehensive directory of diagnostic deals since 2003
  • Diagnostic contract documents
  • Diagnostic agreement terms
  • Diagnostic agreement structure
  • Top diagnostic deals by value
  • Most active diagnostic dealmakers

More details and order

Oncology Partnering Agreements in Pharma, Biotech and Diagnostics

The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies

  • Comprehensive directory of oncology deals since 2003
  • Oncology contract documents
  • Oncology agreement terms
  • Oncology agreement structure
  • Top oncology deals by value
  • Most active oncology dealmakers

More details and order

Option & Evaluation Agreements in Pharma and Biotech

The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies

More details and order

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

The Royalty Financing Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.

More details and order
 

Revised and updated reports:

CurrentPartnering has revised and updated its most popular reports:

Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition

The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies

More details and order

Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 2nd edition

The Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. Revised and updated 2nd edition

More details and order

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

CurrentPartnering’s Practical Guide to Finding Partners in Pharma & Biotech provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity

More details and order

New from Datamonitor:

Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape

Since the financial meltdown, the relationship between Pharma and Biotech has been turned on its head. Previously, pharma companies had no choice but to license Biotech drugs at high prices in order to fill their sparse late stage pipelines

More details and order


Forthcoming events

Here are some of our suggested events for winter 2010:

BioBusiness 2010

London, UK - January 19-20, 2010 - more details

8th Annual BioPartnering North America 2010

Vancouver, B.C., Canada - January 24-26, 2010 - more details

14th Annual Drug Delivery Partnerships

Orlando, FL, USA - January 25-27, 2010 - more details

BIO-Windhover 2010/Pharmaceutical Strategic Outlook 2010

New York, USA - February 23-25, 2010 - more details

EuroPLX 42 Valletta

Portomaso/Valletta, Malta - March 1-2, 2010 - more details

BioEurope Spring 2010

Barcelona, Spain - March 8-10, 2010 - more details

Collaborations, Deals and Alliances

Philadelphia, PA, USA - April 11-14, 2010 - more details

MedTech Investing Europe 2010

Paris, France - April 29-30, 2010 - more details

BIO International Convention 2010

Chicago, IL, USA - May 3-6, 2010 - more details

Annual C21 Bioventures 2010

Napa, CA, USA - May 25-27, 2010 - more details

PharmaPartnering Live 2010

Online powered by ON24 - May 26-27, 2010 - more details

View our full events calendar


People on the move

The following people have been reported on the move during January 2010:

Zachary Zimmerman, Francesco Granata, Kerry Reinertsen, Jeffrey Paulsen, Art Ziegler, Tim Hanke to name just a few

read more about the latest people on the move

If you have news about a business development executive who is on the move - let us know


Partnering resources

Current Partnering maintains and regularly updates this list of useful resources for dealmakers across all industries.

The following topic areas are available - updated regularly:

  • Partnering organizations
  • Financing organizations
  • Online Partnering
  • Weblogs
  • Mentoring/Networking
  • Checklists
  • Quotes
  • Software Tools
  • Library
  • Journals
  • Careers
  • Training/education
  • Other useful links
     

Missing something? Let us know and we will include all appropriate resources.

 


Contact us

Steve Poile, Editor

Web: http://www.CurrentPartnering.com

Mail: CurrentPartnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom

Tel: +44 7896 656732

Fax: +44 8703 305993

Email

 


Advertizing and sponsorship

CurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online.

or contact us to discuss your requirements.

 


About CurrentPartnering

CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers

  • Reports
  • Articles
  • In the news
  • Networks
  • Scorecard
  • Events
  • On the move
  • Careers
  • Glossary
  • Resources
  • Advisers




Sponsored by:

Title






























CurrentPartnering reports

CurrentPartnering is a leading publisher of partnering business intelligence

Here is what our clients say about our reports:

The information you provide is excellent and we look forward to doing more business with you in the future.

...You have published very timely and interesting materials.... I am excited.... It is an excellent publication and pretty well up to date...

- for a full list of our latest publications visit the website at: www.currentpartnering.com

In additon, we list of publishers reports - see full list.






This email was sent to [email address suppressed]
Click here to instantly unsubscribe.

Current Partnering is a registered company in the UK - number 5722617
Registered Office: Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom
Email: info@currentpartnering.com